EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent Advances in Asymmetric Synthesis of 1,4‐Dihydropyridines

Yongqing Ma, Yifeng Huang, Yuxuan Yan, Hongchao Shi, Yongbin Cui, Junmian Yang, Kuo Ren, Jie Feng iD

ChemBioChem · 14.04.2026 · 27 (7)

DOI: 10.1002/cbic.202500894 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemBioChem, online erschienen am 14.04.2026. Verfasst von Yongqing Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical, Pharmaceutical Co Ltd., Shijiazhuang, China. Hauptthemen laut MEDLINE: Dihydropyridines. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 1,4‐dihydropyridine (1,4‐DHP) scaffold is a privileged scaffold in numerous therapeutic agents, including L‐type calcium channel blockers, mineralocorticoid receptor antagonists, and calcitonin gene‐related peptide receptor antagonists. The chirality at the C4 position of the 1,4‐DHP core critically influences its pharmacological activity. Recent advances in asymmetric synthesis, particularly through organocatalysis and transition metal catalysis, have enabled efficient and stereoselective routes to access enantiomerically enriched 1,4‐DHP derivatives. However, a comprehensive review summarizing these asymmetric synthetic strategies for this pivotal scaffold is still lacking. This article systematically summarizes recent progress in the asymmetric synthesis of 1,4‐DHPs, focusing on catalytic systems involving organocatalysts and transition metal complexes. It further highlights their significant potential in constructing key chiral intermediates for pharmaceutical development, aiming to provide novel perspectives for the research and development of chiral 1,4‐DHP‐based drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DihydropyridinesStereoisomerismCatalysis

Stichwörter der Autor:innen

1,4‐dihydropyridine (1,4‐DHP)asymmetric synthesischiral drugsorganocatalysistransition metal catalysis

Substanzen

Dihydropyridines1,4-dihydropyridine

Autor:innen und Institutionen

  • Department of Pharmaceutical, Pharmaceutical Co Ltd., Shijiazhuang, China.
  • Hebei Guangxiang Pharmaceutical Co Ltd., Cangzhou, China.
  • School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China.
  • Department of Organic Chemistry, China Pharmaceutical University, Nanjing, China.

ORCID-Profile: Jie Feng

Zitieren

APA

Ma, Y., Huang, Y., Yan, Y., Shi, H., Cui, Y., Yang, J., Ren, K., & Feng, J. (2026). Recent Advances in Asymmetric Synthesis of 1,4‐Dihydropyridines. ChemBioChem, 27(7). https://doi.org/10.1002/cbic.202500894

Vancouver

Ma Y, Huang Y, Yan Y, Shi H, Cui Y, Yang J, et al. Recent Advances in Asymmetric Synthesis of 1,4‐Dihydropyridines. ChemBioChem. 2026;27(7). doi:10.1002/cbic.202500894

BibTeX
@article{Ma2026,
  author = {Ma, Yongqing and Huang, Yifeng and Yan, Yuxuan and Shi, Hongchao and Cui, Yongbin and Yang, Junmian and Ren, Kuo and Feng, Jie},
  title = {Recent Advances in Asymmetric Synthesis of 1,4‐Dihydropyridines},
  journal = {ChemBioChem},
  year = {2026},
  volume = {27},
  number = {7},
  doi = {10.1002/cbic.202500894}
}
Kostenlos starten →